- Trials with a EudraCT protocol (127)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (15)
127 result(s) found for: Comfort.
Displaying page 1 of 7.
EudraCT Number: 2014-001587-35 | Sponsor Protocol Number: Feline01 | Start Date*: 2014-07-31 |
Sponsor Name:Erasmus Medical Centre, Department of Anesthesiology | ||
Full Title: Dexmedetomidine in awake implantation of neuromodulative systems. | ||
Medical condition: Awake implantation of a neuromodulative system. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002175-24 | Sponsor Protocol Number: 2014_68 | Start Date*: 2015-12-10 |
Sponsor Name:Centre Hospitalier Régional et Universitaire de Lille | ||
Full Title: Effect of the exacyl on perioperative bleeding during surgery of orthognatism of the upper maxillary | ||
Medical condition: Bleeding during surgery of orthognatism of the upper maxillary | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000964-33 | Sponsor Protocol Number: Feline02 | Start Date*: 2015-09-17 |
Sponsor Name:Erasmus Medical Center, Department of Anesthesiology | ||
Full Title: Dexmedetomidine versus propofol in awake implantation of a neuromodulative system. | ||
Medical condition: Awake implantation of a neuromodulative system. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002506-37 | Sponsor Protocol Number: SANNI-project:03 | Start Date*: 2020-01-08 |
Sponsor Name:Region Skane | ||
Full Title: Dexmedetomidine for analgosedation to newborn infants during neonatal intensive care – a prospective pharmacokinetic/ pharmacodynamic/ pharmacogenetic observational study.Cohort 3 in The SANNI Pr... | ||
Medical condition: Sick newborn infants in need of intensive care. | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005091-26 | Sponsor Protocol Number: SANNI-project:02 | Start Date*: 2018-02-13 |
Sponsor Name:Skåne University Hospital | ||
Full Title: Clonidine for analgesia to preterm infants during neonatal intensive care – a prospective pharmacokinetic/pharmacodynamic/pharmacogenetic observational study. Cohort 2 in The SANNI project. | ||
Medical condition: Sick preterm infants undergoing neonatal intensive care. | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002369-37 | Sponsor Protocol Number: GID23 | Start Date*: 2006-09-25 |
Sponsor Name:Sanofi Pasteur SA | ||
Full Title: Lot-to-Lot Consistency Study of the Investigational, Split-virion, Inactivated Influenza Vaccine, Administered by the Intradermal Route in Adults. | ||
Medical condition: Vaccination of adults aged 18 to 60 years with inactivated, split-virion influenza vaccine administered by the intradermal route using Vaxigrip® as IM reference vaccine. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: LT (Completed) ES (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002470-20 | Sponsor Protocol Number: SANNI-project:01 | Start Date*: 2017-04-11 |
Sponsor Name:Skåne University Hospital | ||
Full Title: Fentanyl and Clonidine for analgesia during hypothermia in term asphyxiated infants – a prospective pharmacokinetic/ pharmacodynamic/ pharmacogenetic observational study. Cohort 1 in The SANNI proj... | ||
Medical condition: Infants with induced hypothermic treatment after perinatal asphyxia | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003285-42 | Sponsor Protocol Number: PHT/2005/37 | Start Date*: 2005-11-28 |
Sponsor Name:Portsmouth Institution Medicine, Health & Social Care, Portsmouth University [...] | ||
Full Title: A RCT to test the analgesic efficacy of topical morphine on minor and partial thickness burns in A&E | ||
Medical condition: Minor superficial and partial thickness burns <5% body surface area. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000078-19 | Sponsor Protocol Number: CH/2006/2401 | Start Date*: 2009-03-25 | |||||||||||
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | |||||||||||||
Full Title: Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation | |||||||||||||
Medical condition: Patients must be admitted to PICU and are likely to require intubation and ventilation for more than 48 hours. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001671-36 | Sponsor Protocol Number: EC11-103 | Start Date*: 2012-08-27 |
Sponsor Name:Fundación para la Investigación Biomédica | ||
Full Title: A phase IV randomized, controlled clinical trial to compare the high flow oxygen therapy (group of intervention) opposite to the conventional oxygen therapy (group control) in patients with severe ... | ||
Medical condition: Severe acute respiratory failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002354-72 | Sponsor Protocol Number: 1.0 | Start Date*: 2013-09-05 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie | ||
Full Title: A QUALITATIVE ANALYSIS OF SEDATION IN INFANTS WITH CAUDAL BLOCKADE | ||
Medical condition: 34 patients aged between 0 and 3 months parted into 2 groups have to undergo caudal block. Group 1 receive a block with 1ml/kg Naropin 3.75% Group 2 receive a block with 1ml/kg Naropin 3.75% and... | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002811-33 | Sponsor Protocol Number: LAINCO1107 | Start Date*: 2017-12-11 | |||||||||||
Sponsor Name:LAINCO S.A | |||||||||||||
Full Title: Unilateral, open and randomized phase IV study of 2 groups to assess the degree of comfort with simple Emuliquen® in patients undergoing proctological surgery | |||||||||||||
Medical condition: Surgery proctological | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003991-11 | Sponsor Protocol Number: S55859 | Start Date*: 2013-12-03 |
Sponsor Name:Katholieke Universiteit Leuven | ||
Full Title: Optimization of procedural sedation protocol used for dental care delivery in people with mental disability | ||
Medical condition: Limited cooperation of people with mental disability during regular dental care delivery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-004746-16 | Sponsor Protocol Number: AMCH06071 | Start Date*: 2006-10-30 |
Sponsor Name:Atrium Medisch Centrum Parkstad | ||
Full Title: Darmvoorbereiding bij linkszijdige colonchirurgie | ||
Medical condition: Bowel preparation for elective left-sided colonic surgery will be investigated. Medical conditions requiring this type of treatment vary, examples are inflammatory and malignant diseases. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001469-42 | Sponsor Protocol Number: 35328 | Start Date*: 2011-06-27 |
Sponsor Name:Deventer Ziekenhuis | ||
Full Title: A randomised clinical trial on the effectiveness of MediHoney barrier cream versus the standard therapy with zinc oxide in the treatment of intertrigo. | ||
Medical condition: intertrigo | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000333-40 | Sponsor Protocol Number: 11-534 | Start Date*: 2012-07-30 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: Towards plannable breast surgery: diagnostic accuracy of microbubble enhanced Iodine-125 seed localization of the sentinel lymph node (MIB study) | ||
Medical condition: Patient with breast cancer with an indication for sentinel lymph node biopsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002242-20 | Sponsor Protocol Number: ENT1 | Start Date*: 2013-02-04 |
Sponsor Name:Royal Bournemouth & Christchurch Hospitals NHS Foundation Trust | ||
Full Title: A single-centre, randomised controlled study of Entonox versus midazolam in upper GI endoscopy. | ||
Medical condition: Any patient with symptoms requiring investigation with a gastroscopy. There is no single condition to which this would apply. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2020-000578-31 | Sponsor Protocol Number: SED002 | Start Date*: 2021-01-14 | |||||||||||||||||||||
Sponsor Name:Sedana Medical AB | |||||||||||||||||||||||
Full Title: A Randomised Active-controlled Study to Compare Efficacy and Safety of Inhaled Isoflurane Delivered by the AnaConDa-S (Anaesthetic Conserving Device) to Intravenous Midazolam for Sedation in Mechan... | |||||||||||||||||||||||
Medical condition: Sedation in Mechanically Ventilated Paediatric Patients 3 to 17 (Less than 18) Years Old | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) SE (Completed) FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023155-28 | Sponsor Protocol Number: AGO/2010/006 | Start Date*: 2011-02-14 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: Dexmedetomidine pharmacokinetics-pharmacodynamics in mechanically ventilated neonates with single-organ respiratory failure (NEODEX) | |||||||||||||
Medical condition: Patients admitted to the neonatal intensive care unit with single-organ respiratory failure | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-007053-51 | Sponsor Protocol Number: 003/APR06 | Start Date*: 2007-07-02 | ||||||||||||||||
Sponsor Name:Gloucestershire Hospitals NHS Foundation Trust | ||||||||||||||||||
Full Title: Diamorphine or alfentanil for subcutaneous use in hospice in-patients | ||||||||||||||||||
Medical condition: Palliative Care | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
